trial,pubID,pseudogroup,weeks,group,IgD-/IgM-/IgA-/IgG+/Antigen++ B cells
G002,G002-831,G002,4,2,18646.0
G002,G002-341,G002,4,2,10621.0
G002,G002-852,G002,4,1,7448.0
G002,G002-136,G002,4,2,7725.0
G002,G002-616,G002,4,1,6854.0
G002,G002-502,G002,4,1,9198.0
G002,G002-293,G002,4,2,5712.0
G002,G002-371,G002,4,3,5538.0
G002,G002-630,G002,4,2,5766.0
G002,G002-997,G002,4,3,4507.0
G002,G002-119,G002,4,2,2843.0
G002,G002-477,G002,4,3,7732.0
G002,G002-145,G002,4,2,5829.0
G002,G002-619,G002,4,1,4706.0
G002,G002-758,G002,4,1,3155.0
G002,G002-931,G002,4,3,4618.0
G002,G002-820,G002,4,2,5480.0
G002,G002-516,G002,4,1,2978.0
G002,G002-855,G002,4,2,4323.0
G002,G002-689,G002,4,3,2319.0
G002,G002-493,G002,4,2,1802.0
G002,G002-577,G002,4,2,8487.0
G002,G002-546,G002,4,1,3453.0
G002,G002-796,G002,4,3,3341.0
G002,G002-230,G002,4,2,6150.0
G002,G002-595,G002,4,3,2103.0
G002,G002-813,G002,4,1,1172.0
G002,G002-678,G002,4,1,2984.0
G002,G002-884,G002,4,3,2624.0
G002,G002-254,G002,4,1,2746.0
G002,G002-943,G002,4,2,8009.0
G002,G002-825,G002,4,3,2639.0
G002,G002-957,G002,4,2,3677.0
G002,G002-866,G002,4,3,3034.0
G002,G002-479,G002,4,1,2570.0
G002,G002-278,G002,4,3,2138.0
G002,G002-834,G002,4,1,2796.0
G002,G002-302,G002,4,1,2432.0
G002,G002-733,G002,4,1,4149.0
G002,G002-969,G002,4,1,1441.0
G002,G002-632,G002,4,3,1700.0
G002,G002-304,G002,4,3,1040.0
G002,G002-810,G002,4,3,1705.0
G002,G002-905,G002,4,1,545.0
G002,G002-871,G002,4,3,1442.0
G002,G002-988,G002,4,3,2857.0
G002,G002-427,G002,4,3,417.0
G002,G002-947,G002,4,2,338.0
G002,G002-620,G002,4,2,622.0
G002,G002-480,G002,4,2,331.0
G002,G002-462,G002,4,3,428.0
